Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Morgan Stanley (MS) vs UiPath Inc (PATH) Price & Performance

Morgan StanleyTrade
UiPath IncTrade

Price performance (Past 24H)

Key statistics

Morgan Stanley vs UiPath Inc — how do they compare? Morgan Stanley trades at $187.81 (market cap $297.95B), while UiPath Inc trades at $13.26 (market cap $6.81B). The key difference: Morgan Stanley is far larger — about 43.8× UiPath Inc's market cap, and Morgan Stanley pays a 2.42% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Morgan Stanley for 93 Days and UiPath Inc for 139 Days on average.

MSPATH
Market Cap
$297.95B$6.81B
Volume
5,030,24722,766,109
Sector
FinancialsTechnology
52-Week High
$228.42$19.29
52-Week Low
$151.86$9.38
Typical Hold Time
93 Days139 Days
Enterprise Value
$663.67B$5.61B
Dividend Yield
2.42%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Morgan Stanley

Morgan Stanley (MS) trades at $187.41, down 1.86% on the day, with a bearish technical signal but strong fundamentals including a P/E of 15.32 and net income margin of 27.59%. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, rising from $50.2B in 2022 to $66.0B in 2025, and the company highlights growth opportunities in wealth management and AI financing.

The outlook is supported by a bullish analyst consensus with a $229.25 price target, though risks include volatile cash flows and rising debt-to-asset ratios. Near-term price action is testing support near $184, with investor sentiment mixed amid fading capital markets momentum but positive long-term growth narratives.

UiPath Inc

UiPath (PATH) trades at $13.25, up 1.15% with mixed technical signals showing bearish momentum but neutral oscillators. The company demonstrates improving fundamentals with revenue growing from $1.43B in 2025 to projected $1.7B in 2026, while transitioning from net losses to profitability. Recent partnerships with Snowflake and BDO highlight strategic positioning in AI automation, though the stock faces near-term headwinds from valuation concerns and competitive pressures.

PATH presents a turnaround story with strong revenue growth and path to profitability, but faces execution risks amid competitive automation landscape. The consensus price target of $15.13 suggests 14% upside potential, though technical weakness and mixed analyst sentiment warrant caution. Key catalysts include AI platform adoption and enterprise expansion, while risks involve growth sustainability and margin pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MS
100% Buy0% Sell
Avg holding period · 93 Days
PATH
47% Buy53% Sell
Avg holding period · 139 Days

Top news

Latest headlines on both assets

About Morgan Stanley

Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.

Read more on MS →

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH →